Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

cardiovascular · Mechanism Report

Can LDL particle number be high even when LDL cholesterol is normal?

LDL particle number can be elevated despite normal LDL-C, and this discordance is associated with increased atherosclerotic risk.

SupportedJune 19, 20269 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

LDL particle number can be elevated even when LDL cholesterol is normal, and this discordance is linked to higher atherosclerotic risk.

laying out figure…
All 2 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim describes a common discordance where LDL-C (cholesterol mass) is normal but LDL-P (particle count) is high, meaning standard lipid panels may miss elevated particle burden. Mechanistically, metabolic remodeling produces smaller, cholesterol-depleted LDL particles that increase total particle number and the frequency of arterial wall penetration, raising atherogenic burden and cardiovascular event risk.

Verified conclusion

The clinical measurement of LDL cholesterol (LDL-C) represents the total mass of cholesterol within low-density lipoprotein particles, but it does not account for the total number of particles (LDL-P) circulating in the bloodstream. Extensive research confirms that these two metrics frequently diverge, leading to a state of "discordance" that significantly impacts the assessment of cardiovascular risk.

Clinical evidence of discordance

Research indicates that between 11.6% and 24.3% of the population exhibits discordance between LDL-C and LDL-P levels. In cases where LDL-C is low or normal but LDL-P is high, traditional lipid panels tend to underestimate the risk of atherosclerotic cardiovascular disease (ASCVD).

  • Risk Underestimation: In large cohort studies, relying solely on LDL-C underestimated coronary risk by 20% to 50% in women with discordant measures.
  • Predictive Superiority: LDL-P and its surrogate, Apolipoprotein B (ApoB), consistently outperform LDL-C as predictors of major adverse cardiovascular events (MACE). In specific high-risk genetic cohorts, elevated ApoB/LDL-C ratios have been associated with hazard ratios as high as 38.55 for cardiovascular events.

Mechanistic explanations

The primary driver of discordance is the variation in the composition and size of LDL particles.

  • Small, Dense LDL (sdLDL): In metabolic states such as insulin resistance or metabolic syndrome, LDL particles often become depleted of cholesterol and enriched with triglycerides. This leads to the formation of small, dense LDL particles.
  • Particle Burden: Because each sdLDL particle carries less cholesterol mass, a significantly higher total number of particles is required to transport a given amount of cholesterol.
  • Arterial Penetration: Atherosclerosis is driven by the entry of particles into the arterial wall. A higher LDL-P increases the frequency of arterial wall penetration and subsequent plaque formation, regardless of how much cholesterol each individual particle contains.

Bottom line

LDL-P can be significantly elevated even when LDL-C is normal, identifying a high-risk "low LDL-C–high LDL-P" phenotype often missed by standard testing. This discordance is a critical marker for increased atherosclerotic risk because it more accurately reflects the total burden of atherogenic particles in the vasculature.

References

  1. Abstract 18619: All Advanced Lipid Tests are Not Equal: Prospective Analysis of Discordance Between LDL-P, Small Dense LDL (or Subfractions), and HDL-P (or Subfractions) as Determined by NMR, Ion Mobility, and VAP in Treated Patients — ahajournals.org ↗
  2. Low-density lipoprotein particle profiles compared with standard lipids measurements in the association with asymptomatic intracranial artery stenosis — pmc.ncbi.nlm.nih.gov ↗
  3. Discordance of Low-Density Lipoprotein (LDL) Cholesterol With Alternative LDL-Related Measures and Future Coronary Events — pmc.ncbi.nlm.nih.gov ↗
  4. Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol — pmc.ncbi.nlm.nih.gov ↗
  5. ApoB/LDL-C discordance as a predictor of atherosclerotic cardiovascular disease in genetically confirmed heterozygous familial hypercholesterolemia: A hypothesis-generating cohort study. — linkinghub.elsevier.com ↗
  6. 260-OR: The ApoB/LDL-C Ratio Predicts Major Cardiovascular Events in Cardiovascular Disease Patients Independent of Type 2 Diabetes Status — diabetesjournals.org ↗
  7. ApoB, LDL-C, and non-HDL-C as markers of cardiovascular risk. — linkinghub.elsevier.com ↗
  8. Triglyceride/low-Density-Lipoprotein Cholesterol (TG/LDL-C) Ratio is the Most Diagnostically Valuable Predictor for Increased Small, Dense LDL in Type 2 Diabetes Patients — researchsquare.com ↗
  9. Triglyceride/low-density-lipoprotein cholesterol ratio is the most valuable predictor for increased small, dense LDL in type 2 diabetes patients — lipidworld.biomedcentral.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible10 sourcesAre F2-isoprostanes biomarkers of lipid peroxidation and does oxidized LDL contribute to atherosclerosis?→Plausible10 sourcesDo hs-CRP, Lp-PLA2, and myeloperoxidase reflect different cardiovascular risk signals?→